Cytoplasmic expression of estrogen receptor beta (ERβ) predicts poor clinical outcome in advanced serous ovarian cancer

Gian Franco Zannoni, Anna Fagotti, Giovanni Scambia, Ilaria De Stefano, Giuseppe Vizzielli, Mg Prisco, L Tortorella, L Mencaglia, D. Gallo

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

In this study we investigated the prognostic value of estrogen receptor α (ERα), ERβ and progesterone receptor (PR) expression in 58 untreated advanced serous ovarian cancer patients. The study also included 12 macroscopically and histopathologically normal ovaries.
Lingua originaleEnglish
pagine (da-a)573-579
Numero di pagine7
RivistaGynecologic Oncology
Volume122
DOI
Stato di pubblicazionePubblicato - 2011

Keywords

  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols
  • Carboplatin
  • Cell Nucleus
  • Cisplatin
  • Cohort Studies
  • Cystadenocarcinoma, Serous
  • Cytoplasm
  • Disease-Free Survival
  • Estrogen Receptor alpha
  • Estrogen Receptor beta
  • Female
  • Humans
  • Immunohistochemistry
  • Middle Aged
  • Ovarian Neoplasms
  • Paclitaxel
  • Receptors, Progesterone

Fingerprint Entra nei temi di ricerca di 'Cytoplasmic expression of estrogen receptor beta (ERβ) predicts poor clinical outcome in advanced serous ovarian cancer'. Insieme formano una fingerprint unica.

Cita questo